ClinicalTrials.govpublic full text
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
prostatic neoplasms, prostatic neoplasma, castration-resistant, neuroendocrine differentiation, 68ga-dotatet, pet/ct, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874013
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.